Industry Outlook & Insights
Big Data is a term that has spurred hope and promises for drug discovery through optimizing patient treatment and care, all said to reduce cost, increase quality and effectiveness of care and make patients and providers happier. Increasing and on-going efforts have been made in the areas of data collection from medical records, devices, wearables, claims, tests and sequencing. No matter what the source or type of data, the promises have been equally as wide. Yet, the progression from research to clinical value has not moved as fast or with the all the promised results.
There is no question that digitalization and datafication have become new health care engines. The on-going collection and compilation of health data now available to develop better care and solutions for patients and health professionals is showing results. In this session, datafication in the health care and medtech industries will be discussed and explored from the solutions and platforms perspectives, including ethics, showing how under which conditions health data can be shared and utilized to protect individuals while delivering on the industry wide promises of data. The session will be a benchmark on how to build advanced legislative and business environments for collecting and utilizing health data to create more value for patients, companies and governments alike. Special focus will be paid to the conditions for developing data-driven healthcare in the US and in the Nordics. Finland’s actual success in data integration and management has been used to build a revolutionary win-win-win situation for patients, companies and government. This session also serves as an invitation for the on-going dialogue and collaboration between the different players from society, companies – startups through global corporations, government and academia to learn and move to the next step of actual value from data driven health care.